tiprankstipranks
Trending News
More News >
AsiaPhos Limited (SG:5WV)
SGX:5WV
Singapore Market

AsiaPhos Limited (5WV) AI Stock Analysis

Compare
0 Followers

Top Page

SG:5WV

AsiaPhos Limited

(SGX:5WV)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
S$0.01
▲(0.00% Upside)
The overall stock score of 50 reflects the company's strong revenue growth but significant challenges in profitability and cash flow management. Technical indicators suggest a bearish trend, while the valuation appears fair. The absence of earnings call insights and corporate events limits further analysis.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for AsiaPhos's products and suggests successful market penetration, supporting long-term business expansion.
Improved Leverage
Reduced leverage enhances financial stability and reduces risk, providing AsiaPhos with greater flexibility to invest in growth opportunities.
Sustainable Practices
Commitment to sustainability aligns with global trends, potentially enhancing brand reputation and opening new market opportunities in eco-conscious sectors.
Negative Factors
Profitability Challenges
Negative margins indicate operational inefficiencies that could hinder long-term financial health unless addressed, impacting overall profitability.
Cash Flow Issues
Negative operating cash flow suggests liquidity constraints, which may limit the company's ability to fund operations and growth initiatives sustainably.
Return on Equity Decline
A declining return on equity indicates inefficiencies in generating returns from investments, potentially affecting investor confidence and long-term growth prospects.

AsiaPhos Limited (5WV) vs. iShares MSCI Singapore ETF (EWS)

AsiaPhos Limited Business Overview & Revenue Model

Company DescriptionAsiaPhos Limited, an investment holding company, manufactures and sells in phosphate-based chemical products in India, Ireland, Japan, Malaysia, and internationally. It operates through two segments: Upstream and Downstream Segments. The company trades sodium trimetaphosphate, sodium tripolyphosphate, sodium hexametaphosphate, tetrapotassium pyrophosphate, disodium phosphate, monosodium phosphate, sodium acid pyrophosphate, monopotassium phosphate, dipotassium phosphate, tetrapotassium pyrophosphate, potassium tripolyphosphate, monoammonium phosphate, phosphorus pentoxide, phosphoric acid, red phosphorus, iron phosphate, aluminium phosphate, zinc phosphate, and potassium formate; and fertilizers. It also involved in the investing in chemical projects; general wholesale trade and trading of chemicals; business development; wholesale of mineral products; mining activities; renewable energy business; and provision of internet technology consulting and transportation services. In addition, the company engages in the exploration, mining, and sale of phosphate rocks; and production and sale of phosphorus and phosphate based chemical products. AsiaPhos Limited was founded in 1996 and is based in Singapore.
How the Company Makes MoneyAsiaPhos Limited generates revenue through the manufacturing and sale of its phosphate products, which are critical for agricultural applications. The company's revenue model is primarily based on direct sales to agricultural distributors, cooperatives, and farmers. Key revenue streams include the sales of various phosphate fertilizers and related products. Additionally, AsiaPhos benefits from long-term contracts with agricultural enterprises and partnerships with distributors, which help stabilize income and ensure consistent demand for its products. The company's focus on sustainable practices and innovation in phosphate production also positions it advantageously in a growing market, contributing to its overall earnings.

AsiaPhos Limited Financial Statement Overview

Summary
AsiaPhos Limited exhibits strong revenue growth but faces significant profitability and cash flow challenges. The balance sheet shows improved leverage, but the company struggles with generating returns on equity. Overall, while there are positive signs of growth, the company needs to address operational inefficiencies and cash flow management to ensure sustainable financial health.
Income Statement
AsiaPhos Limited has shown significant revenue growth of 92.94% in the latest year, indicating a strong recovery. However, the company struggles with profitability, as evidenced by negative EBIT and EBITDA margins, suggesting operational inefficiencies. The net profit margin is positive due to non-operational factors, which may not be sustainable.
Balance Sheet
The company has improved its debt-to-equity ratio to 0.05, indicating reduced leverage and better financial stability. However, the return on equity has decreased significantly, suggesting challenges in generating returns from equity investments. The equity ratio is not provided, limiting further analysis.
Cash Flow
Operating cash flow is negative, indicating potential liquidity issues. Despite a positive free cash flow to net income ratio, the free cash flow growth rate is high, but this is from a low base, suggesting volatility. The operating cash flow to net income ratio is negative, highlighting cash flow management challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.72M4.29M1.70M2.42M1.57M846.00K
Gross Profit507.00K367.00K328.00K500.00K215.00K89.00K
EBITDA-458.00K-2.28M-3.68M-822.00K-3.50M-2.84M
Net Income-278.00K1.17M2.07M-1.56M-65.97M-2.77M
Balance Sheet
Total Assets3.55M4.59M21.05M17.78M21.85M108.77M
Cash, Cash Equivalents and Short-Term Investments2.12M1.43M865.00K757.00K2.88M848.00K
Total Debt143.00K159.00K3.06M5.97M8.59M7.37M
Total Liabilities1.02M1.17M21.25M19.30M20.99M30.92M
Stockholders Equity2.55M3.38M2.33M1.01M3.40M68.54M
Cash Flow
Free Cash Flow-3.32M-4.87M-5.00K-3.29M-2.69M-739.00K
Operating Cash Flow-3.29M-4.84M170.00K-3.26M-2.68M-720.00K
Investing Cash Flow-205.00K9.60M-175.00K1.84M4.39M533.00K
Financing Cash Flow-607.00K-3.78M167.00K-437.00K256.00K639.00K

AsiaPhos Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
50
Neutral
S$13.32M10.00156.33%-52.38%
46
Neutral
S$39.49M-1.70-19.55%0.92%-7.45%-480.22%
45
Neutral
S$49.71M-2.12-20.85%-2.43%52.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:5WV
AsiaPhos Limited
0.01
0.00
0.00%
SG:C05
Chemical Industries Far East Ltd.
0.52
0.06
13.04%
SG:5DS
MegaChem Ltd.
0.42
0.00
0.00%
SG:A55
Asia Enterprises Holding Ltd.
0.17
0.04
28.91%
SG:BAZ
Lion Asiapac Limited
0.24
0.06
33.52%
SG:C8R
Jiutian Chemical Group Limited
0.03
>-0.01
-7.41%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 14, 2025